Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Aug;43(8):1773-83.
doi: 10.1007/s10803-012-1723-5.

Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study

Justine M Kent  1 , Stuart Kushner, Xiaoping Ning, Keith Karcher, Seth Ness, Michael Aman, Jaskaran Singh, David Hough
Affiliations
Randomized Controlled Trial

Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study

Justine M Kent et al. J Autism Dev Disord. 2013 Aug.

Abstract

Efficacy and safety of 2 risperidone doses were evaluated in children and adolescents with autism. Patients (N = 96; 5-17 years), received risperidone (low-dose: 0.125 mg/day [20 to <45 kg], 0.175 mg/day [>45 kg] or high-dose: 1.25 mg/day [20 to <45 kg], 1.75 mg/day [>45 kg]) or placebo. Mean baseline (range 27-29) to endpoint change in Aberrant Behavior Checklist-Irritability (primary endpoint) was significantly greater in the high-dose-(-12.4 [6.5]; p < 0.001), but not low-dose (-7.4 [8.1]; p = 0.164) group, versus placebo (-3.5 [10.7]). Clinical Global Impressions-Severity and Children's Yale-Brown Obsessive Compulsive Scale scores improved significantly only in the high-dose group, consistent with ABC-I results. Somnolence, sedation and increased appetite occurred more frequently in high-versus low-dose groups. Overall, increased appetite occurred most frequently.

Trial registration: ClinicalTrials.gov NCT00576732.

PubMed Disclaimer

References

    1. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 2):8-13 - PubMed
    1. J Clin Psychiatry. 2003;64 Suppl 4:16-25 - PubMed
    1. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):140-7 - PubMed
    1. Am J Ment Defic. 1985 Mar;89(5):492-502 - PubMed
    1. J Neurovirol. 2005 Feb;11(1):1-10 - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources